Literature DB >> 16223732

Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1.

Huasheng Lu1, Clifton L Dalgard, Ahmed Mohyeldin, Thomas McFate, A Sasha Tait, Ajay Verma.   

Abstract

Continuous hydroxylation of the HIF-1 transcription factor alpha subunit by oxygen and 2-oxoglutarate-dependent dioxygenases promotes decay of this protein and thus prevents the transcriptional activation of many genes involved in energy metabolism, angiogenesis, cell survival, and matrix modification. Hypoxia blocks HIF-1alpha hydroxylation and thus activates HIF-1alpha-mediated gene expression. Several nonhypoxic stimuli can also activate HIF-1, although the mechanisms involved are not well known. Here we show that the glucose metabolites pyruvate and oxaloacetate inactivate HIF-1alpha decay in a manner selectively reversible by ascorbate, cysteine, histidine, and ferrous iron but not by 2-oxoglutarate or oxygen. Pyruvate and oxaloacetate bind to the 2-oxoglutarate site of HIF-1alpha prolyl hydroxylases, but their effects on HIF-1 are not mimicked by other Krebs cycle intermediates, including succinate and fumarate. We show that inactivation of HIF-1 hydroxylation by glucose-derived 2-oxoacids underlies the prominent basal HIF-1 activity commonly seen in many highly glycolytic cancer cells. Since HIF-1 itself promotes glycolytic metabolism, enhancement of HIF-1 by glucose metabolites may constitute a novel feed-forward signaling mechanism involved in malignant progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16223732     DOI: 10.1074/jbc.M508718200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  146 in total

Review 1.  Complex role of the HIF system in cardiovascular biology.

Authors:  Gabor Czibik
Journal:  J Mol Med (Berl)       Date:  2010-06-24       Impact factor: 4.599

Review 2.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

3.  Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury.

Authors:  Rongxue Wu; Kirsten M Smeele; Eugene Wyatt; Yoshihiko Ichikawa; Otto Eerbeek; Lin Sun; Kusum Chawla; Markus W Hollmann; Varun Nagpal; Sami Heikkinen; Markku Laakso; Kentaro Jujo; J Andrew Wasserstrom; Coert J Zuurbier; Hossein Ardehali
Journal:  Circ Res       Date:  2010-11-11       Impact factor: 17.367

4.  Searching for the elusive mitochondrial longevity signal in C. elegans.

Authors:  Christopher F Bennett; Haeri Choi; Matt Kaeberlein
Journal:  Worm       Date:  2014-10-30

Review 5.  Targeting lactate metabolism for cancer therapeutics.

Authors:  Joanne R Doherty; John L Cleveland
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

6.  Pyruvate protects the brain against ischemia-reperfusion injury by activating the erythropoietin signaling pathway.

Authors:  Myoung-Gwi Ryou; Ran Liu; Ming Ren; Jie Sun; Robert T Mallet; Shao-Hua Yang
Journal:  Stroke       Date:  2012-01-26       Impact factor: 7.914

Review 7.  The role of HIF proteins in maintaining the metabolic health of the intervertebral disc.

Authors:  Elizabeth S Silagi; Ernestina Schipani; Irving M Shapiro; Makarand V Risbud
Journal:  Nat Rev Rheumatol       Date:  2021-06-03       Impact factor: 20.543

Review 8.  Ocular neovascularization.

Authors:  Peter A Campochiaro
Journal:  J Mol Med (Berl)       Date:  2013-01-18       Impact factor: 4.599

9.  Mitochondrial mutations contribute to HIF1alpha accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma.

Authors:  Wenyue Sun; Shaoyu Zhou; Steven S Chang; Thomas McFate; Ajay Verma; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

10.  Normoxic accumulation of HIF1α is associated with glutaminolysis.

Authors:  Matthias Kappler; Ulrike Pabst; Swetlana Rot; Helge Taubert; Henri Wichmann; Johannes Schubert; Matthias Bache; Claus Weinholdt; Uta-Dorothee Immel; Ivo Grosse; Dirk Vordermark; Alexander W Eckert
Journal:  Clin Oral Investig       Date:  2016-03-09       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.